Head-to-head comparison
| Property | TB-500 | GHK-Cu |
|---|---|---|
| Category | Recovery | Skin & Beauty |
| Legal Status | Reclassification Pending | Unregulated |
| Primary Route | subcutaneous | topical |
| Half-life | ~4 hours | ~1 hour (plasma) |
| Mol. Weight | 4,963 Da | 403.93 Da |
| Side Effects | Headache, Nausea, Injection site pain | Injection site irritation, Skin redness (topical), Mild stinging (topical) |
Key differences
- Structure: TB-500 is a synthetic fragment of thymosin beta-4 (43 amino acids); GHK-Cu is a tripeptide (3 amino acids) complexed with a copper(II) ion.
- Primary application: TB-500 is most studied for deep tissue repair, wound healing, and cardiac recovery; GHK-Cu is most studied for skin regeneration, collagen synthesis, and cosmetic anti-aging.
- Mechanism: TB-500 upregulates actin for cell migration and has anti-inflammatory effects; GHK-Cu activates metalloproteinases, stimulates collagen/elastin production, and recruits immune cells.
- Routes: TB-500 is administered subcutaneously or intramuscularly; GHK-Cu is commonly applied topically (skincare) or injected subcutaneously.
- Human data: GHK-Cu has published human clinical studies in dermatology; TB-500 evidence is primarily preclinical and veterinary.
- Availability: GHK-Cu is widely available in over-the-counter cosmetic products; TB-500 is primarily available as a research compound.
- Anti-aging profile: GHK-Cu has extensive research on reversing skin aging markers; TB-500 anti-aging research is focused on tissue repair capacity rather than cosmetic effects.
The verdict
TB-500 and GHK-Cu are better understood as complementary rather than competing peptides. GHK-Cu is the stronger choice for skin-focused goals (wrinkle reduction, collagen stimulation, surface wound healing) with the advantage of human clinical data and topical availability. TB-500 is more relevant for deep tissue injury, cardiac recovery, and systemic repair protocols. For comprehensive regeneration protocols, some practitioners discuss using both.
Frequently asked questions
TB-500 and GHK-Cu work through different mechanisms and target different tissue types, making them potentially complementary rather than redundant. No clinical studies have evaluated this combination, but their distinct pathways suggest low interaction risk.
GHK-Cu has more direct evidence for skin healing, including human clinical studies demonstrating increased collagen synthesis, improved skin thickness, and accelerated wound closure. GHK-Cu is also available in topical formulations for direct skin application.
For deep tissue injuries (muscle tears, cardiac damage, ligament injury), TB-500 has more relevant preclinical data. GHK-Cu is better supported for surface wounds and skin repair. BPC-157 is also commonly considered alongside both for musculoskeletal recovery.
GHK-Cu is significantly easier to obtain as it is available in over-the-counter skincare products (serums, creams) without a prescription. TB-500 is primarily available as a research compound and is under FDA reclassification review.